Understanding colorectal cancer differences in African Americans and their social factors
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
This study is looking into why African Americans have higher rates of colorectal cancer and worse outcomes than non-Hispanic Whites, focusing on both genetic and social factors, to help find better ways to screen and treat this group.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11013853 on NIH RePORTER |
What this research studies
This research investigates the reasons behind higher colorectal cancer rates and poorer outcomes in African Americans compared to non-Hispanic Whites. It aims to explore the genetic and social factors that contribute to these disparities, focusing on tumor biology and socioeconomic conditions. By analyzing a diverse group of African American patients, the study seeks to uncover how these factors influence cancer progression and survival rates. The findings could lead to improved screening and treatment strategies tailored to this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals diagnosed with colorectal cancer.
Not a fit: Patients who do not identify as African American or those with colorectal cancer not related to the factors being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for colorectal cancer in African Americans, ultimately improving survival rates.
How similar studies have performed: Previous research has shown that understanding genetic and social factors can significantly impact cancer treatment outcomes, suggesting this approach has potential for success.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Rozek, Laura — Georgetown University
- Study coordinator: Rozek, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.